Visceral leishmaniasis: current situation and future perspectives

Alvar J, Canavate C, Gutierrez-Solar B et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin. Microbiol. Rev. 1997; 10 (2): 298-319.

Badaro R, Jones T, Lorenço R et al. A prospective study of visceral Leishmaniasis in an endemic area of Brazil. J. Inf. Dis. 1986: 154: 639-649.

Berman JD. Human Leishmaniasis: clinical, diagnostic and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 1997; 24: 684-703.

Coler RN and Reed SG. Second-generation vaccines against Leishmaniasis. Trends Parasitol 2005; 21 (5): 244-249.

Desjeux P. Leishmaniasis: current situation and new perspectives. Comparative Immunology, Microbiol. Infect. Dis. 2004; 27: 305318.

Evans TG, Teixeira MJ, Mcauliffe IT et al. Epidemiology of visceral Leishmaniasis in Northeast Brazilian. J. Inf. Dis. 1992; 166: 1124-1132.

Guerrin PJ, Olliaro P, boelaert M et al. Visceral Leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect. Dis. 2002; 2 (8): 494-501.

Lainson R, Shaw JJ. Evolution, classification and geographical distribution. In: Peters W; Killick- Kendrick R. The Leishmaniasis in biology and medicine. Eds. London, Academic Press Inc., 1 (cap.7):p.1-120, 1987.

Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Manual de vigilância e controle da Leishmaniose Visceral. Brasília (DF) 2004.

Murray HW. Treatment of visceral Leishmaniasis in 2004. Am J Trop Med Hyg. 2004; 71 (6): 787-94.

Rosenthal E and Marty P. Recent understanding in the treatment of visceral Leishmaniasis. J Postgrad. Med. 2003 49:61-82.

Singh S and Sivakumar R. Challenges and new discoveries in the treatment of Leishmaniasis. J Infect Chemother 2004; 10 (6): 307-15.

World Heath Organization. Division of control of tropical disease. Leishmaniasis control. Geographical distribution. 2005. WHO/CTD. Disponível em:

Moddaber, F. Development of vaccines against Leishmaniasis. Scand. J. Infect. Dis. 1990; 76: 72-78.

Momeni AL, Jalayer T, Emamjomeh M et al. A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous Leishmaniasis in Iran. Vaccine 1998; 17: 466-472.